On June 2, 2025, Madar Holding signed a partnership with Saidal and a group of Algerian researchers, under the supervision of the Ministry of Pharmaceutical Industry.
The agreement aims to establish Algeria’s first national laboratory for developing and producing human and veterinary vaccines, a strategic step toward strengthening health sovereignty.
The project reflects Madar Holding’s commitment to supporting national scientific innovation and pharmaceutical research and development.
Through this lab, Algeria will be able to produce vaccines locally to meet citizen and animal needs, reducing reliance on foreign imports.
This project exemplifies Madar Holding’s dedication to serving the public and enhancing national capacity to address health challenges.
